1. Home
  2. PFSA vs SPRC Comparison

PFSA vs SPRC Comparison

Compare PFSA & SPRC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

PFSA

Profusa Inc.

N/A

Current Price

$0.52

Market Cap

3.7M

Sector

Health Care

ML Signal

N/A

Logo SciSparc Ltd.

SPRC

SciSparc Ltd.

N/A

Current Price

$4.40

Market Cap

4.0M

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
PFSA
SPRC
Founded
2009
2004
Country
United States
Israel
Employees
N/A
N/A
Industry
Medical/Dental Instruments
Biotechnology: Pharmaceutical Preparations
Sector
Health Care
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
3.7M
4.0M
IPO Year
N/A
2014

Fundamental Metrics

Financial Performance
Metric
PFSA
SPRC
Price
$0.52
$4.40
Analyst Decision
Analyst Count
0
0
Target Price
N/A
N/A
AVG Volume (30 Days)
213.1K
83.6K
Earning Date
04-02-2026
03-23-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$0.05
$0.23
52 Week High
$4.22
$8.90

Technical Indicators

Market Signals
Indicator
PFSA
SPRC
Relative Strength Index (RSI) 35.23 63.38
Support Level $0.46 $3.62
Resistance Level $0.66 $4.85
Average True Range (ATR) 0.10 0.52
MACD -0.06 -0.04
Stochastic Oscillator 16.76 31.58

Price Performance

Historical Comparison
PFSA
SPRC

About PFSA Profusa Inc.

Profusa Inc is a clinical-stage digital health and medical technology company focused on developing biosensing solutions to improve health outcomes for patients with a variety of different diseases and conditions. The Company's technology enables the development of bioengineered sensors that are designed to become one with the body to detect and continuously transmit actionable, clinical-grade data for personal and medical use. The Company's first offering in the European Union, the Lumee Oxygen Platform, is designed to report reliable tissue oxygen levels at various regions of interest, both acutely and long-term.

About SPRC SciSparc Ltd.

SciSparc Ltd is a specialty clinical stage pharmaceutical company. It is engaged in developing several immunotherapy products and it owns patents in the immunotherapy field. It is focused on creating and enhancing a portfolio of technologies and assets based on cannabinoid pharmaceuticals. The company has two reportable segments; development of drugs based on cannabinoid molecules to be approved by an official regulatory authority (the company's operation); and online sales of a various range of hemp-based products including hemp gummies, hemp oil capsules, hemp gel, hemp cream, detox pills, height pills, antibacterial creams, and anti-aging creams, among other beauty and hair treatment products that are all manufactured in the United States.

Share on Social Networks: